All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @drjencaudle on TikTok · 76s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @drjencaudle's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Here's the ways to manage gastrointestinal side effects from GLP1s, things you can try at home, which might help your symptoms.
  2. 0:07Number one is to eat smaller meals. Make sure you're not eating big meals, small meals, and eat slowly.
  3. 0:13Please do not rush through your meals. Also, with that said, eat when you're hungry and then when you get full,
  4. 0:19make sure you stop eating, okay?
  5. 0:22Other things is when you finish eating, you know, try not to lay down immediately. That could potentially make symptoms worse.
  6. 0:29And sometimes people feel better when they don't use straws.
  7. 0:32See, straws sometimes can introduce air into the gastrointestinal tract and make you feel bloated and stuff like that.
  8. 0:37So, you know, that is something that I do recommend.
  9. 0:41The other thing is you want to make sure you're drinking plenty of water, not too much because you can drink too much water,
  10. 0:45but plenty of water and fiber, you're getting exercise. And then pay attention to your diet.
  11. 0:51So, you know, sticking to sort of low fat, sort of a low fat healthy diet probably is going to be your best bet.
  12. 0:58As opposed to things that are high cholesterol, high fat, fried foods, you know, sugary things like that may further upset your stomach.
  13. 1:05There are other things you can try at home. I also have some tricks that your doctor may also be able to try with you to help you deal with the GLP1 side effects.
  14. 1:12Just message me if you would like the full video on Dr. Jen.

GLP-1 side effect tips: what actually works vs. what sounds good

DrJenCaudle

TikTok creator

36.3K viewsWatch on TikTok

Quick answer

GLP-1 receptor agonists cause gastrointestinal side effects, primarily nausea, vomiting, and bloating, in approximately 30-50% of users, driven largely by delayed gastric emptying. Dietary modifications including smaller low-fat meals and upright posture post-meal are consistent with standard clinical guidance and manufacturer prescribing information for agents like semaglutide and tirzepatide. Dose titration remains the most evidence-supported primary intervention for persistent GI symptoms and was not addressed in this video.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For GLP-1 side effect tips: what actually works vs. what sounds good, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

GLP-1 side effect tips: what actually works vs. what sounds good is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "GLP-1 side effect tips: what actually works vs. what sounds good" from DrJenCaudle. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: GLP-1 receptor agonists cause gastrointestinal side effects, primarily nausea, vomiting, and bloating, in approximately 30-50% of users, driven largely by delayed gastric emptying.

The reason this review is not generic is the source wording and the canonical claim label "glp1 how to reduce side effects of these medications drjencaudle." In this clip, the useful excerpt is: "Here's the ways to manage gastrointestinal side effects from GLP1s, things you can try at home, which might help your symptoms." That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Eating smaller, lower-fat meals is mechanistically sound advice: large high-fat meals compound the drug's own gastric slowing effect (Horowitz et al.
People who land here are usually comparing the GLP-1 social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' GLP-1 social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

GLP-1 receptor agonists cause gastrointestinal side effects, primarily nausea, vomiting, and bloating, in approximately 30-50% of users, driven largely by delayed gastric emptying.

FormBlends verdict

GLP-1 social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • GLP-1 receptor agonists cause gastrointestinal side effects, primarily nausea, vomiting, and bloating, in approximately 30-50% of users, driven largely by delayed gastric emptying. Dietary modifications including smaller low-fat meals and upright posture post-meal are consistent with standard clinical guidance and manufacturer prescribing information for agents like semaglutide and tirzepatide. Dose titration remains the most evidence-supported primary intervention for persistent GI symptoms and was not addressed in this video.
  • GLP-1 agonists cause nausea in approximately 30-50% of users, primarily due to delayed gastric emptying, not gastrointestinal irritation.
  • Eating smaller, lower-fat meals is mechanistically sound advice: large high-fat meals compound the drug's own gastric slowing effect (Horowitz et al., 1993, Gut).

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • GLP-1 agonists cause nausea in approximately 30-50% of users, primarily due to delayed gastric emptying, not gastrointestinal irritation.
  • Eating smaller, lower-fat meals is mechanistically sound advice: large high-fat meals compound the drug's own gastric slowing effect (Horowitz et al., 1993, Gut).
  • Dose titration is the most evidence-supported tool for reducing GI side effects and was shown to cut discontinuation rates in the STEP trial semaglutide program (Wilding et al., 2021, NEJM).
  • The straw recommendation is the least evidence-based claim in the video. Aerophagia from straws is real but has not been studied specifically in GLP-1 populations.
  • GI symptoms from GLP-1s are largely transient. Pooled semaglutide trial data shows nausea rates decline significantly after the first 20 weeks regardless of dietary interventions.
  • Persistent or severe vomiting on a GLP-1 is a prescriber issue, not a home-management problem. Dehydration risk is real and should not be managed with behavioral tips alone.
  • The video correctly avoids dosing language, disease-cure claims, and supplement stacking. It stays within appropriate over-the-counter lifestyle advice for a short-form format.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @drjencaudle actually say?

Dr. Jen Caudle, a board-certified family physician, offered a list of at-home strategies for managing gastrointestinal side effects from GLP-1 receptor agonists. Her recommendations included eating smaller, slower meals, stopping when full, avoiding lying down after eating, skipping straws, staying hydrated, getting fiber and exercise, and sticking to a low-fat diet. She called out "fried foods" and "sugary things" as likely to worsen symptoms. She also hinted at a fuller video with additional medical strategies available through her platform.

The tone is measured. No dramatic claims, no dosing language, no suggestion these drugs cure disease. That baseline matters.

Does the science back this up?

Largely, yes. Most of these recommendations are consistent with what the clinical literature supports for GLP-1-related GI distress, which affects roughly 30-50% of users depending on the agent and titration schedule.

The advice to eat smaller meals and slow down aligns with the known mechanism: GLP-1 agonists delay gastric emptying significantly. A 2022 review by Wilding et al. in Diabetes, Obesity and Metabolism noted that nausea and vomiting from semaglutide are largely tied to the drug's effect on gastric motility, meaning meal size and composition directly influence symptom load. Eating slowly and stopping at satiety cues is not folk wisdom here, it is mechanistically sound.

The low-fat dietary advice also has support. High-fat meals are independently associated with delayed gastric emptying (Horowitz et al., 1993, Gut), which compounds the drug's own slowing effect. Recommending against fried and fatty foods is legitimate.

The straw recommendation is the most speculative of the bunch, though it is not wrong per se.

What did they get wrong (or right)?

Credit where it is due: most of this is right. The smaller meals, low-fat diet, upright posture after eating, and hydration guidance are all defensible and consistent with manufacturer prescribing information and GI literature. Dr. Caudle gets the mechanism directionally correct without overstating it.

The straw advice is the weakest link. She says straws "can introduce air into the gastrointestinal tract" and cause bloating. Aerophagia from straw use is a real phenomenon, but the clinical evidence specifically linking straw use to GLP-1-related GI symptoms is thin. It is a reasonable extrapolation from general GI best practices, not a drug-specific finding. Calling it something she "does recommend" gives it more clinical weight than the evidence supports.

One omission worth noting: she does not mention the importance of dose titration as a primary tool for managing side effects. The STEP trials (Wilding et al., 2021, New England Journal of Medicine) showed that slow titration schedules significantly reduced GI discontinuation rates. That is arguably the most evidence-backed intervention available, and it requires a prescriber conversation, which she gestures at but does not name explicitly.

What should you actually know?

If you are on a GLP-1 and dealing with nausea, vomiting, or bloating, the behavioral tips in this video are a reasonable starting point. They are not going to work for everyone, and they are not a substitute for talking to your prescriber about your titration schedule.

The bigger picture: GI side effects from GLP-1 agonists are dose-dependent and largely transient. A 2021 pooled analysis of semaglutide trials found that nausea rates dropped substantially after the first 20 weeks even without dietary changes (Davies et al., 2021, Lancet). Behavioral strategies may reduce discomfort during that window, but they do not change the underlying pharmacology.

If symptoms are severe, persistent, or include vomiting that interferes with hydration, that is a prescriber conversation, not a home-management problem. Dr. Caudle gestures at this by mentioning additional things doctors can try, which is the right instinct even if the video does not spell it out fully.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

DrJenCaudle · TikTok creator

36.3K views on this video

How to reduce side effects of these medications #drjencaudle #fyp #fypシ #fypage #fypシ゚viral

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about glp-1 agonists cause nausea in approximately 30-50% of users, primarily?

GLP-1 agonists cause nausea in approximately 30-50% of users, primarily due to delayed gastric emptying, not gastrointestinal irritation.

What does the video say about eating smaller, lower-fat meals?

Eating smaller, lower-fat meals is mechanistically sound advice: large high-fat meals compound the drug's own gastric slowing effect (Horowitz et al., 1993, Gut).

Dose titration is the most evidence-supported tool for reducing GI side effects and was shown to cut discontinuation rates in the STEP trial semaglutide program (Wilding et al., 2021, NEJM)?

Dose titration is the most evidence-supported tool for reducing GI side effects and was shown to cut discontinuation rates in the STEP trial semaglutide program (Wilding et al., 2021, NEJM).

What does the video say about the straw recommendation?

The straw recommendation is the least evidence-based claim in the video. Aerophagia from straws is real but has not been studied specifically in GLP-1 populations.

What does the video say about gi symptoms from glp-1s?

GI symptoms from GLP-1s are largely transient. Pooled semaglutide trial data shows nausea rates decline significantly after the first 20 weeks regardless of dietary interventions.

What does the video say about persistent?

Persistent or severe vomiting on a GLP-1 is a prescriber issue, not a home-management problem. Dehydration risk is real and should not be managed with behavioral tips alone.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by DrJenCaudle, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.